JMVNX Performance — Mid Value Fund, Class NAV
Data updated: 2026-07-27
JMVNX returned +14.62% year to date and +26.64% over one year to May 2026. Annualised returns are +18.73% over 3 years and +10.16% over 5 years. The fund beat its US Mid-Cap Value category average: $100 invested three years ago grew to $167, against $154 for the category, and to $127 over one year, against $121. Volatility over the past three years was 16.11% a year. In the 12 months to May 2026 the fund lost a net $158.2M, and assets reached $1.34B.
JMVNX Growth of $100
What $100 invested in Mid Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | JMVNX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $127 | $121 |
| 3 years (Jun 2023 – May 2026) | $167 | $154 |
| 5 years (Jun 2021 – May 2026) | $162 | $148 |
| Since data start (Sep 2019 – May 2026) | $244 | $211 |
JMVNX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +14.62% |
| 1 year | +26.64% |
| 3 years (annualised) | +18.73% |
| 5 years (annualised) | +10.16% |
JMVNX Annual Returns
Calendar-year total returns of Mid Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +14.62% |
| 2025 | +5.99% |
| 2024 | +16.21% |
| 2023 | +18.63% |
| 2022 | −4.25% |
| 2021 | +24.20% |
| 2020 | +9.74% |
| 2019 (Sep–Dec) | +11.43% |
JMVNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.1% | +5.0% | −6.3% | +8.0% | +2.5% | — | — | — | — | — | — | — |
| 2025 | +3.9% | −2.4% | −4.3% | −6.1% | +5.3% | +2.0% | +1.5% | +4.2% | +0.8% | −0.9% | +2.2% | +0.3% |
| 2024 | +0.1% | +4.6% | +6.3% | −4.7% | +3.1% | −1.3% | +5.5% | +0.7% | +1.6% | −0.3% | +6.8% | −6.5% |
| 2023 | +10.3% | −2.4% | −4.3% | +0.7% | −3.6% | +8.7% | +4.8% | −3.2% | −5.1% | −5.1% | +9.3% | +9.2% |
| 2022 | −1.2% | +2.0% | +3.8% | −5.2% | +0.9% | −10.0% | +6.4% | −3.0% | −9.3% | +10.5% | +7.6% | −4.4% |
| 2021 | +0.4% | +8.0% | +5.5% | +4.1% | +3.2% | −2.7% | −1.9% | −0.3% | −0.7% | +4.9% | −3.9% | +6.1% |
| 2020 | −3.9% | −6.8% | −20.4% | +15.9% | +3.5% | +2.0% | +6.1% | +4.2% | −5.4% | +0.6% | +13.3% | +5.6% |
| 2019 | — | — | — | — | — | — | — | — | +3.4% | +0.4% | +3.1% | +4.1% |
JMVNX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 16.11%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +9.26% (Nov 2023)
- Worst month: −6.47% (Dec 2024)
JMVNX Fund Flows
Monthly money in and out of Mid Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$158.2M
- 12-month gross sales (incl. reinvestments): $150.8M
- Sales ÷ redemptions: 0.49×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $885K | $11.5M | −$10.6M |
| Apr 2026 | $423K | $15.3M | −$14.8M |
| Mar 2026 | $5.2M | $8.7M | −$3.5M |
| Feb 2026 | $430K | $84.0M | −$83.6M |
| Jan 2026 | $1.6M | $34.0M | −$32.4M |
| Dec 2025 | $130.9M | $35.1M | $95.8M |
| Nov 2025 | $821K | $10.5M | −$9.6M |
| Oct 2025 | $3.3M | $1.4M | $1.9M |
| Sep 2025 | $3.4M | $20.6M | −$17.1M |
| Aug 2025 | $1.3M | $24.7M | −$23.5M |
| Jul 2025 | $812K | $46.7M | −$45.9M |
| Jun 2025 | $1.7M | $16.7M | −$14.9M |
JMVNX Assets Under Management
Net assets of Mid Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $1.34B |
| 2026-02-28 | $1.32B |
| 2025-11-30 | $1.33B |
| 2025-08-31 | $1.33B |
| 2025-05-31 | $1.31B |
| 2025-02-28 | $1.36B |
| 2024-11-30 | $1.52B |
| 2024-08-31 | $1.50B |
| 2024-05-31 | $1.48B |
| 2024-02-29 | $1.49B |
| 2023-11-30 | $1.42B |
| 2023-08-31 | $1.44B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.